Crescita Therapeutics Inc Cash Flow-to-Debt Ratio
Crescita Therapeutics Inc cash flow-to-debt ratio. Crescita Therapeutics Inc (CTX) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of CA$416.00K could theoretically repay 0% of its total liabilities (CA$4.75 Million) in one year. Check how high is Crescita Therapeutics Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Crescita Therapeutics Inc (2014–2025)
Cash flow-to-debt ratio of Crescita Therapeutics Inc from 2014 to 2025. Historical debt coverage capacity for Crescita Therapeutics Inc across 12 annual periods. Check total reinvestment intensity of Crescita Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Crescita Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
Crescita Therapeutics Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Crescita Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Crescita Therapeutics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CA$1.07 Million | CA$4.75 Million | ▼ -50.7% |
| 2024 | 0.46x | CA$2.73 Million | CA$5.95 Million | ▲ +27.5% |
| 2023 | 0.36x | CA$2.08 Million | CA$5.78 Million | ▲ +360.3% |
| 2022 | -0.14x | CA$-1.02 Million | CA$7.39 Million | ▲ +27.4% |
| 2021 | -0.19x | CA$-1.60 Million | CA$8.40 Million | ▼ -119.3% |
| 2020 | 0.98x | CA$5.61 Million | CA$5.70 Million | ▲ +6.3% |
| 2019 | 0.93x | CA$5.31 Million | CA$5.73 Million | ▲ +636.3% |
| 2018 | -0.17x | CA$-1.48 Million | CA$8.56 Million | ▲ +77.9% |
| 2017 | -0.78x | CA$-7.40 Million | CA$9.46 Million | ▲ +31.7% |
| 2016 | -1.15x | CA$-18.58 Million | CA$16.21 Million | ▲ +62.5% |
| 2015 | -3.06x | CA$-13.92 Million | CA$4.55 Million | ▼ -22.8% |
| 2014 | -2.49x | CA$-9.30 Million | CA$3.74 Million | — |